Recipients


EFSD/MSD Programme



2012:

Juergen
Eckel - German Diabetes Center - Duesseldorf, Germany
Adipose tissue-derived DPP4 as a mediator of the development of obesity-associated adipose tissue inflammation and type 2 diabetes

Sander
Kersten - Wageningen University - The Netherlands
The entero-endocrine factor ANGPTL4 as regulator of glucose and lipid metabolism

Filip
Knop - University of Copenhagen - Denmark
Delineating pancreatic and extrapancreatic effects of the incretin hormones in man

Nils
Wierup - University of Lund - Sweden
Antidiabetic actions of CART

Sagen
Zac-Varghese - Imperial College London - UK
A comparative study of L cells following LKB1 deletion in mice and following bariatric surgery

2011:

Gabriela
da Silva Xavier -
Imperial College London - UK
The role of TCF7L2 in pancreatic islet cell survival and sensitivity to GLP-1

Thierry Ferreira
- Poitiers University - France
A yeast-based screening strategy of new drugs and target genes with therapeutical perspectives in type 2 diabetes

Dominique Gauguier
- Cordeliers Research Centre - Paris, France
Transcription landscapes of Glis3-induced gene expression in pancreatic islets

Guy Rutter
- Imperial College London - UK
The type 2 diabetes-associated secretory granule zinc transporter ZnT8 (SLC30A8) as a potential drug target

Shanna Tam
- St Vincent's Institute, Fitzroy - Australia
Does LKB1 modulate wingless type MMTV integration site (Wnt) signalling in pancreatic beta cells?

Ram Weiss - Hebrew University, Jerusalem, Israel
Islet function in response to bariatric surgery in patients with pre-diabetes and diabetes

Jakob Wikstrom - Hebrew University, Jerusalem - Israel
The role of UPR-autophagy cross-talk in the regulation of beta cell fate in diabetes

2010:


Nils
Billestrup
- University of Copenhagen - Denmark
Regulation of beta cell growth and apoptosis by bone morphogenetic proteins and activin

Charna Dibner - University Hospital of Geneva - Switzerland
Beta cell circadian clock impact on insulin secretion and glucose homeostasis

Jochen Lang - Bordeaux University - Pessac, France
Adenylate cyclase 8: beta cell signalling, survival and glucose homeostasis

Stephan Schneider - Ruhr-University Bochum - Germany
Multimodel imaging of beta cells

Anders Tengholm - Uppsala University - Sweden
Kinetic control of insulin secretion by sub-plasma membrane cAMP signalling

Bernard Thorens - Lausanne University - Switzerland
IGF-2 and the IGF-1 receptor in the control of beta cell mass and function

Mireille Vasseur-Cognet - Paris Descartes University - France
COUP-TFll: an essential transcription factor for functional pancreatic beta cell mass

2009:

 Sebastian Barg - Uppsala University - Sweden

Dynamic association of voltage-gated Ca2+ channels with docked insulin granules

Anne Grapin-Botton - Swiss Institute - Lausanne, Switzerland
In vivo imaging of endocrine islets

Jean-Christophe Jonas - Catholic University of Louvain - Brussels, Belgium
Role of beta cell hypoxia in the pathophysiology of type 2 diabetes

Hindrik Mulder - Lund University - Sweden
Melatonin and its receptors in pancreatic islets - elucidating the role of a novel type 2 diabetes gene

Romano Regazzi - University of Lausanne - Switzerland
Identification of microRNAs involved in the control of the functional beta cell mass

Susanna Törnroth-Horsefield - University of Gothenburg – Sweden
Beta cell dysfunction and type 2 diabetes - structural studies of UP and TH

2008:

Bernadette Breant -
University Pierre et Marie Curie – Paris, France
The role of glucorticoids on pancreas development and the induction of type 2 diabetes: genetic approach in mice and in vitro studies

Harry Heimberg -
Free University Brussels - Belgium
Activation and expansion of beta cell progenitors in the adult pancreas

Patrick Jacquemin -
Louvain Catholic University – Brussels, Belgium
Beta cell neogenesis in hnf6-/- mice: characterisation and translation of the underlying mechanism to the production of beta cells in vitro

Kathrin Maedler -
University of Bremen - Germany
Genetic modifications in the TCF7L2 gene regulate beta cell function and survival in type 2 diabetes

Stephan Speier -
Karolinska Institutet - Stockholm, Sweden
Non-invasive in vivo imaging of pancreatic functional beta cell mass regulation 

Emmanuel Van Obberghen -
Nice University Hospital - France
Beta cell failure and progression to type 2 diabetes: role of muscle-derived molecules

2007:

Amar Abderrahmani -
UCHUV-Hospital - Lausanne, Switzerland
Role of human oxidised low density lipoprotein and high density lipoprotein in pancreatic beta cells: relevance for the molecular pathogenesis of diabetes

Stefano del Prato -
University of Pisa - Italy
Prevalence of the TCF7L2 polymorphisms in a high risk type 2 diabetes population and their role in determining different pathogenic features as well as response to incretin-based therapy

Marc Donath -
University Hospital Zurich - Switzerland
Regulation of islet inflammatory CXC chemokines and angiogenesis by the Fas-FLIP pathway

Valdemar Grill -
University Hospital Trondheim - Norway
Mitochondrial plasticity and function in beta cells: effects of diabetes and hypoxia

Noel Morgan -
Peninsula Medical School - Plymouth, UK
Mechanisms by which interleukin-4 protects pancreatic beta cells against pro-inflammatory cytokine induced cell death

Hindrick Mulder -
Lund University - Sweden
Metabolic analysis of pancreatic beta cells

Shanta Persaud - King's College London - UK
Role of p8 in beta cell mass expansion and survival


2006:

Lena Eliasson -
Lund University - Sweden
Role of miR-375 and its target proteins in insulin secretion

Jorge Ferrer -
Fundacio Clinic Barcelona - Spain
Novel insights into the role of Dipetidylpeptidase IV in pancreatic beta-cell function

Françoise Homo-Delarche -
Paris 7 University - France
Islet vasculopathy in type 2 diabetes: the Goto-Kakizaki (GK) rat paradigm

Leif Jansson -
Uppsala University - Sweden
Blood lipids and pancreatic islet blood flow: possible pathogenetic importance for type 2 diabetes

Andreas Lechner -
Ludwig-Maximilians-University - Munich, Germany
Analysis of the functional role of osteoprotegerin (OPG) in pancreatic islets

Michael Ristow -
Jena University - Germany
Maintenance of pancreatic beta-cell mass by conditional knock-in of mitochondrial frataxin into diabetes-prone mice

Stephan Schneider -
Ruhr-University Bochum - Germany
In vivo imaging of the islet-cell mass in normal and diabetic states

Anders Tengholm -
Uppsala University - Sweden
Spatio-temporal dynamics of cAMP signals in pancreatic beta cells


2005:

Francesco Beguinot -
Federico II University - Naples, Italy
The control of beta-cell function by ped/pea-15 gene and its abnormality in type 2 diabetes

Peter Bergsten -
Uppsala University - Sweden
Unravelling mechanisms of beta cell glucolipotoxicity

Marc Donath -
Zurich University - Switzerland
Regulation of beta-cell secretory function via FAS signalling

Jean-Christophe Jonas -
Louvain Catholique University - Brussels, Belgium
Mechanisms of beta cell glucotoxicity

Erik Renström -
Lund University - Sweden
Identification of candidate genes for type 2 diabetes: Molecular investigations of mechanisms for defective insulin secretion related to a major species-conserved susceptibility locus

Emmanuel Van Obberghen -
INSERM - Nice, France
Role of SOCS proteins in beta cell function and survival